Patents by Inventor Eckart Fleck

Eckart Fleck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Semifluorocarbon Compound Containing Contrast Agent
    Publication number: 20230355810
    Abstract: The present invention relates to an aqueous emulsion comprising a) a semifluorinated compound of formula I: CF3—(CF2)x—(CH2)y—CH3 ??(I) ?wherein x is an integer ranging from 1 to 8 and y is an integer ranging from 2 to 10, b) a triglyceride which is miscible with the semifluorinated compound at 20° C.; and c) an emulsifier.
    Type: Application
    Filed: May 2, 2023
    Publication date: November 9, 2023
    Inventors: Thorsten Keller, Doris Rothlein, Jurgen Schmitt, Thore Dietrich, Philipp Stawowy, Eckart Fleck
  • Pre-saturation of the liver and subsequent administration of the contrast agent
    Patent number: 10786583
    Abstract: The present invention relates to an aqueous formulation for use in diagnostic detection wherein the aqueous formulation is administered prior to the administration of a fluorinated contrast agent or composition comprising a fluorinated contrast agent as well as to a method of administration. The invention further relates to the use of said aqueous formulation for the diagnostic detection of inflammatory pathological conditions using MR imaging. In addition the invention relates to a kit as well as a diagnostic kit suitable for use in diagnostic detection.
    Type: Grant
    Filed: September 25, 2014
    Date of Patent: September 29, 2020
    Assignee: B.Braun Melsungen AG
    Inventors: Thore Dietrich, Riad Bourayou, Eckart Fleck, Thorsten Keller, Jürgen Schmitt, Doris Röthlein
  • Calibration of MRI systems using pre-defined concentrations of F isotopes as reference
    Patent number: 10725137
    Abstract: A kit for calibrating a magnetic resonance imaging (MRI) system using defined concentration of 19F isotopes as well as a device for calibrating a MRI system using the kit. Further, a method for calibrating a MRI system employing the kit as well as to an entity comprising a defined concentration of 19F isotopes to be used in the calibration of a MRI system.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: July 28, 2020
    Assignee: B. BRAUN MELSUNGEN AG
    Inventors: Thorsten Keller, Thore Dietrich, Eckart Fleck
  • CALIBRATION OF MRI SYSTEMS USING PRE-DEFINED CONCENTRATIONS OF 19F ISOTOPES AS REFERENCE
    Publication number: 20190041483
    Abstract: A kit for calibrating a magnetic resonance imaging (MRI) system using defined concentration of 19F isotopes as well as a device for calibrating a MRI system using the kit. Further, a method for calibrating a MRI system employing the kit as well as to an entity comprising a defined concentration of 19F isotopes to be used in the calibration of a MRI system.
    Type: Application
    Filed: February 1, 2017
    Publication date: February 7, 2019
    Inventors: THORSTEN KELLER, THORE DIETRICH, ECKART FLECK
  • Pre-Saturation of the Liver and Subsequent Administration of the Contrast Agent
    Publication number: 20160228582
    Abstract: The present invention relates to an aqueous formulation for use in diagnostic detection wherein the aqueous formulation is administered prior to the administration of a fluorinated contrast agent or composition comprising a fluorinated contrast agent as well as to a method of administration. The invention further relates to the use of said aqueous formulation for the diagnostic detection of inflammatory pathological conditions using MR imaging. In addition the invention relates to a kit as well as a diagnostic kit suitable for use in diagnostic detection.
    Type: Application
    Filed: September 25, 2014
    Publication date: August 11, 2016
    Inventors: Thore Dietrich, Riad Bourayou, Eckart Fleck, Thorsten Keller, Jürgen Schmitt, Doris Röthlein
  • Semifluorocarbon Compound Containing Contrast Agent
    Publication number: 20160000941
    Abstract: The present invention relates to an aqueous emulsion comprising a) a semifluorinated compound of formula I: CF3—(CF2)x—(CH2)y—CH3(I) wherein x is an integer ranging from 1 to 8 and y is an integer ranging from 2 to 10, b) a triglyceride which is miscible with the semifluorinated compound at 20° C.; and c) an emulsifier.
    Type: Application
    Filed: March 18, 2014
    Publication date: January 7, 2016
    Inventors: Thorsten Keller, Doris Rothlein, Jurgen Schmitt, Thore Dietrich, Philipp Stawowy, Eckart Fleck
  • Process for reducing the formation of artifacts during transcription of ribonucleic acids to deoxynucleic acids
    Patent number: 6124093
    Abstract: A method of transcribing ribonucleic acids of a sample by treating the sample containing ribonucleic acid with a DNA digesting enzyme in the presence of Mn.sup.2+ ions followed by transcribing the ribonucleic acids into deoxyribonucleic acids and suitable reagents.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: September 26, 2000
    Assignee: Roche Diagnostics GmbH
    Inventors: Peter Bauer, Arndt Rolfs, Vera Regitz-Zagrosek, Eckart Fleck